UBC researchers Art Cherkasov and Paul Rennie of the Vancouver Prostate Centre are tackling the deadliest forms of prostate cancer, using a brand new field of genomics called computational chemogenomics to develop a novel class of prostate cancer drugs in order to provide new treatment options for this disease. This new approach uses computer modeling in virtual 3D to predict how different chemicals or drugs will affect cancer tumours.
The project, titled “Methods of Chemical Genomics” has received $324,000 in funding, with $161,500 from Genome BC and the rest from other partners including the Canadian Institutes of Health Research and the Vancouver Prostate Centre.
For more information, visit http://www.prostatecentre.com/node/253